Cardiac failure 30 years after treatment containing anthracycline for childhood acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 5, 2012, Pages 395-397

  Goldberg, John M ^a,b,c   Scully, Rebecca E ^a,d   Sallan, Stephen E ^e   Lipshultz, Steven E ^a,b,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cancer survivorship; heart failure; late effects

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; CARVEDILOL; COLECALCIFEROL; DIGOXIN; DOXORUBICIN; ENALAPRIL; FUROSEMIDE; IRON; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMENORRHEA; ARTICLE; BACKACHE; BARIATRIC SURGERY; BODY MASS; CANCER REGRESSION; CARDIOTOXICITY; CASE REPORT; CHILD; CHILDHOOD LEUKEMIA; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE COURSE; DRUG DOSE REDUCTION; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HIP PAIN; HUMAN; INDUCTION CHEMOTHERAPY; IRON DEFICIENCY ANEMIA; MIGRAINE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONCOLOGY; PACEMAKER; PATIENT COMPLIANCE; PEDIATRIC CARDIOLOGY; PRIORITY JOURNAL; SKULL IRRADIATION; SUDDEN DEATH; TRANSFORMED MIGRAINE; TREATMENT DURATION; TREATMENT RESPONSE; VIRAL UPPER RESPIRATORY TRACT INFECTION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ANTIBIOTICS, ANTINEOPLASTIC; CHILD, PRESCHOOL; DOXORUBICIN; FEMALE; HEART FAILURE; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84862857481     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182532078     Document Type: Article

References (43)

1. Sallan SE, Hitchcock-Bryan S, Gelber R, et al. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res. 1983;43:5601-5607. (Pubitemid 14230187)
2. Lipshultz SE, Lipsitz SR, Sallan SE, et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol. 2005;23: 2629-2636. (Pubitemid 46179451)
3. Gianni L, Herman EH, Lipshultz SE, et al. Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol. 2008;26: 3777-3784.
4. Furman L, Camitta BM, Jaffe N, et al. Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary report. Med Pediatr Oncol. 1976;2: 157-166.
5. Lipshultz SE. Heart failure in childhood cancer survivors. Nat Clin Pract Oncol. 2007;4:334-335. (Pubitemid 46864303)
6. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808-815.
7. Lipshultz SE, Lipsitz SR, Mone SM, et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med. 1995;332: 1738-1743.
8. Lipshultz SE, Rifai N, Dalton VM, et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med. 2004;351:145-153. (Pubitemid 38886649)
9. Davis M. Gender differences in p-glycoprotein: drug toxicity and response. J Clin Oncol. 2005;23:6439-6440. (Pubitemid 46218857)
10. Thompson PA, Rosner GL, Matthay KK, et al. Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study. Cancer Chemother Pharmacol. 2009;64:243-251.
11. Krischer JP, Epstein S, Cuthbertson DD, et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol. 1997;15:1544-1552. (Pubitemid 27167391)
12. Garmey EG, Liu Q, Sklar CA, et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2008;26:4639-4645.
13. Armstrong GT, Sklar CA, Hudson MM, et al. Long-term health status in adult survivors of childhood cancer: does gender matter? J Clin Oncol. 2007;25:4477-4489. (Pubitemid 350063805)
14. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313. (Pubitemid 34815352)
15. Qureshi MY, Wilkinson JD, Lipshultz SE. The relationship of childhood obesity with cardiomyopathy and heart failure. In: Lipshultz SE, Miller TL, Messiah SE, eds. Pediatric Metabolic Syndrome: Comprehensive Clinical Review and Related Health Issues. London, UK: Springer Verlag; 2012:199-216.
16. Lavie CJ, Osman AF, Milani RV, et al. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003;91:891-894. (Pubitemid 36363743)
17. Miller TL, Lipsitz SR, Lopez-Mitnik G, et al. Characteristics and determinants of adiposity in pediatric cancer survivors. Cancer Epidemiol Biomarkers Prev. 2010;19:2013-2022.
18. Ashrafian H, le Roux CW, Darzi A, et al. Effects of bariatric surgery on cardiovascular function. Circulation. 2008;118: 2091-2102.
19. Oreopoulos A, Ezekowitz JA, McAlister FA, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc. 2010;85: 609-617.
20. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency: an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008;52:1949-1956.
21. Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93:3927-3935.
22. Lipshultz SE, Lipsitz SR, Sallan SE, et al. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol. 2002;20: 4517-4522. (Pubitemid 35402954)
23. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077-1084. (Pubitemid 30207690)
24. Silber JH, Cnaan A, Clark BJ, et al. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol. 2004;22:820-828. (Pubitemid 41103593)
25. Arico M, Pedroni E, Nespoli L, et al. Long term survival after heart transplantation for doxorubicin induced cardiomyop-athy. Arch Dis Child. 1991;66:985-986.
26. Levitt G, Bunch K, Rogers CA, et al. Cardiac transplantation in childhood cancer survivors in Great Britain. Eur J Cancer. 1996;32A:826-830.
27. Levitt G, Anazodo A, Burch M, et al. Cardiac or cardiopul-monary transplantation in childhood cancer survivors: an increasing need? Eur J Cancer. 2009;45:3027-3034.
28. McManus RP, O'Hair DP. Pediatric heart transplantation for doxorubicin-induced cardiomyopathy. J Heart Lung Transplant. 1992;11:375-376.
29. Ward KM, Binns H, Chin C, et al. Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare. J Heart Lung Transplant. 2004;23:1040-1045. (Pubitemid 39345647)
30. Fricker FJ, Addonizio L, Bernstein D, et al. Heart transplantation in children: indications. Report of the Ad Hoc Subcommittee of the Pediatric Committee of the American Society of Transplantation (AST). Pediatr Transplant. 1999;3:333-342.
31. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572-1582. (Pubitemid 44547808)
32. Bublik N, Alvarez JA, Lipshultz SE. Pediatric cardiomyopathy as a chronic disease: a perspective on comprehensive care programs. Prog Pediatr Cardiol. 2008;25:103-111.
33. Zeltzer LK, Recklitis C, Buchbinder D, et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2396-2404.
34. Zebrack BJ, Zeltzer LK, Whitton J, et al. Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma: a report from the Childhood Cancer Survivor Study. Pediatrics. 2002;110(pt 1):42-52. (Pubitemid 34742639)
35. Recklitis CJ, Diller LR, Li X, et al. Suicide ideation in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2010;28:655-661.
36. Recklitis CJ, Lockwood RA, Rothwell MA, et al. Suicidal ideation and attempts in adult survivors of childhood cancer. J Clin Oncol. 2006;24:3852-3857. (Pubitemid 46630731)
37. Tindle HA, Omalu B, Courcoulas A, et al. Risk of suicide after long-term follow-up from bariatric surgery. Am J Med. 2010; 123:1036-1042.
38. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96. (Pubitemid 351521864)
39. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2004, Based on November 2006 SEER Data Submission, Posted to the SEER Web Site 2007. Bethesda, MD: National Cancer Institute; 2006.
40. Ries LAG, Smith MA, Gurney JG, et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. SEER Program. NIH Pub No 99-4649,99-4649. Bethesda, MD: National Cancer Institute; 1999.
41. Pein F, Sakiroglu O, Dahan M, et al. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer. 2004;91:37-44. (Pubitemid 39013042)
42. Booser DJ, Perez-Soler R, Cossum P, et al. Phase I study of liposomal annamycin. Cancer Chemother Pharmacol. 2000;46: 427-432.
43. Barry E, Alvarez JA, Scully RE, et al. Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin Pharmacother. 2007;8:1039-1058. (Pubitemid 46929299)